H. A. Razeq, P. Cottu, A. Ring, M. de Laurentiis, Janice M. Lu, H. Azim, C. Zamagni, K. Zhou, Jiwen Wu, L. Menon-Singh, Miguel Martín
{"title":"摘要:Ribociclib +来曲唑治疗激素受体阳性(HR+)、人表皮生长因子受体2阴性(HER2−)晚期乳腺癌(ABC)的绝经前患者:IIIb期complement -1试验的亚组分析","authors":"H. A. Razeq, P. Cottu, A. Ring, M. de Laurentiis, Janice M. Lu, H. Azim, C. Zamagni, K. Zhou, Jiwen Wu, L. Menon-Singh, Miguel Martín","doi":"10.1158/1538-7445.sabcs20-ps10-10","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20307,"journal":{"name":"Poster Session Abstracts","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract PS10-10: Ribociclib + letrozole in premenopausal patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Subgroup analysis of the phase IIIb CompLEEment-1 trial\",\"authors\":\"H. A. Razeq, P. Cottu, A. Ring, M. de Laurentiis, Janice M. Lu, H. Azim, C. Zamagni, K. Zhou, Jiwen Wu, L. Menon-Singh, Miguel Martín\",\"doi\":\"10.1158/1538-7445.sabcs20-ps10-10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20307,\"journal\":{\"name\":\"Poster Session Abstracts\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Poster Session Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.sabcs20-ps10-10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster Session Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.sabcs20-ps10-10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract PS10-10: Ribociclib + letrozole in premenopausal patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Subgroup analysis of the phase IIIb CompLEEment-1 trial